Dr. Mary Bailey, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $560,242 | 215 | 76.1% |
| Consulting Fee | $98,469 | 39 | 13.4% |
| Travel and Lodging | $37,065 | 85 | 5.0% |
| Food and Beverage | $15,640 | 389 | 2.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $13,240 | 2 | 1.8% |
| Honoraria | $10,300 | 7 | 1.4% |
| Education | $1,142 | 17 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $229,710 | 208 | $0 (2024) |
| Genentech USA, Inc. | $117,309 | 96 | $0 (2024) |
| EMD Serono, Inc. | $78,559 | 58 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $76,821 | 99 | $0 (2023) |
| TG Therapeutics, Inc. | $70,146 | 35 | $0 (2024) |
| GENZYME CORPORATION | $69,747 | 56 | $0 (2023) |
| Celgene Corporation | $39,156 | 33 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $17,041 | 22 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $15,656 | 94 | $0 (2019) |
| Horizon Therapeutics plc | $10,680 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59,125 | 49 | TG Therapeutics, Inc. ($32,235) |
| 2023 | $113,452 | 74 | TG Therapeutics, Inc. ($36,111) |
| 2022 | $109,341 | 65 | Biogen, Inc. ($39,683) |
| 2021 | $51,789 | 35 | Biogen, Inc. ($17,374) |
| 2020 | $49,514 | 48 | Celgene Corporation ($24,014) |
| 2019 | $147,891 | 130 | Novartis Pharmaceuticals Corporation ($42,628) |
| 2018 | $105,662 | 104 | Biogen, Inc. ($42,666) |
| 2017 | $99,323 | 249 | Biogen, Inc. ($48,326) |
All Payment Transactions
754 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Neurology | ||||||
| 09/26/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 09/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Biogen, Inc. | VUMERITY (Drug) | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| Category: Neurology | ||||||
| 09/01/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/23/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,243.00 | General |
| Category: Neurology | ||||||
| 08/15/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 08/15/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Neurology | ||||||
| 08/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $31.97 | General |
| 07/19/2024 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,055.00 | General |
| Category: Neurology | ||||||
| 07/18/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.74 | General |
| Category: Neuroscience | ||||||
| 06/13/2024 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,055.00 | General |
| Category: Neurology | ||||||
| 05/24/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Neurology | ||||||
| 05/23/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $817.37 | General |
| Category: Neurology | ||||||
| 05/23/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $317.20 | General |
| Category: Neurology | ||||||
| 05/22/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: Immunology | ||||||
| 05/22/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.74 | General |
| Category: Neuroscience | ||||||
| 05/15/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.50 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 82 | 108 | $25,596 | $10,115 |
| 2022 | 2 | 77 | 100 | $22,712 | $9,110 |
| 2021 | 2 | 75 | 103 | $22,739 | $8,957 |
| 2020 | 3 | 103 | 132 | $27,736 | $9,755 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 108 | $25,596 | $10,115 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 87 | $20,619 | $8,405 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 13 | $2,093 | $705.23 | 33.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 81 | $19,197 | $7,375 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 22 | $3,542 | $1,582 | 44.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 66 | $15,642 | $5,157 | 33.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 46 | $7,406 | $2,793 | 37.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 20 | $4,688 | $1,805 | 38.5% |
About Dr. Mary Bailey, MD
Dr. Mary Bailey, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558543686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Bailey, MD has received a total of $736,098 in payments from pharmaceutical and medical device companies, with $59,125 received in 2024. These payments were reported across 754 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($560,242).
As a Medicare-enrolled provider, Bailey has provided services to 337 Medicare beneficiaries, totaling 443 services with total Medicare billing of $37,937. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location New Haven, CT
- Active Since 11/30/2007
- Last Updated 10/11/2012
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558543686
Products in Payments
- TECFIDERA (Drug) $79,597
- OCREVUS (Biological) $77,897
- BRIUMVI (Drug) $68,346
- AUBAGIO (Drug) $63,023
- VUMERITY (Drug) $49,650
- TYSABRI (Biological) $45,907
- ZEPOSIA (Drug) $40,263
- Mavenclad (Drug) $37,607
- MAVENCLAD (Drug) $27,096
- Ocrevus (Biological) $18,791
- MAYZENT (Drug) $18,304
- COPAXONE (Drug) $15,069
- Non-Covered Product (Drug) $12,806
- UPLIZNA (Drug) $10,680
- Ozanimod (Drug) $9,535
- KESIMPTA (Drug) $8,616
- GILENYA (Drug) $8,232
- SOLIRIS (Drug) $6,821
- Tysabri (Biological) $5,003
- Mavenclad (Biological) $1,884
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in New Haven
Dr. Christopher Bunick, M.d., Ph.d, M.D., PH.D
Student in an Organized Health Care Education/Training Program — Payments: $438,598
Ariel Lefland, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $219,448
Dr. Ryan Hebert, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $49,268
Mariam Totonchy
Student in an Organized Health Care Education/Training Program — Payments: $26,095
Dr. Henry Park, M.d., M.p.h, M.D., M.P.H
Student in an Organized Health Care Education/Training Program — Payments: $24,811
Dr. Leslie Blackburn, D.d.s, D.D.S
Student in an Organized Health Care Education/Training Program — Payments: $23,738